Processa Pharmaceuticals (PCSA) News
NASDAQ: PCSAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PCSA news summary
We found 4 recent headlines mentioning Processa Pharmaceuticals (PCSA): 0 in the past week and 4 in the past 30 days, most often from Nasdaq, GlobeNewswire. PCSA is making an outsized move today, down 7.69% at $1.56, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Processa Pharmaceuticals, Inc. Appoints Gregory J. Flesher as Chief Operating Officer and Announces Key Leadership Additions", was published by Nasdaq on Nov 4, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Processa Pharmaceuticals headlines
- Processa Pharmaceuticals, Inc. Appoints Gregory J. Flesher as Chief Operating Officer and Announces Key Leadership AdditionsProcessa Pharmaceuticals, Inc. announced that its Board of Directors approved the appointment of Gregory J. Flesher as Chief Operating Officer, effective November 4, 2026. Under his employment…Nasdaq
- Processa Pharmaceuticals Announces Key Leadership AppointmentsVERO BEACH, FL, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company advancing differentiated…GlobeNewswire
- Processa Pharmaceuticals, Inc. Appoints Dr. Sheila Gujrathi as Executive Chair and Announces FDA Clearance of Phase 2 IND for VT-7208Processa Pharmaceuticals, Inc. announced that on October 27, 2026, Justin Yorke resigned as chair of the board of directors, and on October 28, 2026, the board appointed Dr. Sheila Gujrathi as the…Nasdaq
- Processa Pharmaceuticals Announces Corporate and Pipeline Progress Following Acquisition of Vidya TherapeuticsVERO BEACH, FL, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company developing VT-7208, a Bruton's…GlobeNewswire